Bingsong Han

Senior Director at Atavistik Bio | Greater Boston

About Bingsong Han

Bingsong Han currently serves as the Director of Medicinal Chemistry at Sage Therapeutics, where he leverages over 20 years of extensive experience in drug discovery across multiple therapeutic areas, including oncology, central nervous system (CNS) disorders, and immunology. In his role, Bingsong is not only a program leader but also a pivotal figure in shaping the strategic direction of various CNS and immunology programs. His expertise in medicinal chemistry allows him to lead the design and prioritization of novel molecules, ensuring that the drug discovery pipeline remains robust and innovative.

Bingsong's leadership is characterized by his ability to effectively manage both internal teams and external contract research organizations (CROs), fostering collaboration that drives projects forward. He excels in project planning, budgeting, and execution, ensuring that each program is aligned with the overarching goals of Sage Therapeutics. His hands-on approach to chemistry exploration has been instrumental in advancing early and late-stage drug discovery programs, where he has successfully generated critical data that informs decision-making and accelerates timelines.

With a strong foundation in organic synthesis and a deep understanding of the complexities of drug development, Bingsong is adept at navigating the challenges inherent in bringing new therapies to market. His commitment to scientific excellence and his strategic vision make him a key contributor to Sage Therapeutics' mission of developing transformative treatments for patients with serious CNS disorders. Through his leadership, Bingsong continues to push the boundaries of medicinal chemistry, driving innovation and enhancing the therapeutic landscape.

Bingsong Han Work